Should you buy MYOB Group Ltd or XERO FPO NZ?

MYOB Group Ltd will hit the ASX in May, but how will it compete with XERO FPO NZ (ASX:XRO)?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

After months of speculation, accounting software giant MYOB Group Ltd has finally lodged its initial public offer (IPO) prospectus with the Australian Securities and Investments Commission (ASIC), outlining its intentions to raise up to $833.8 million from retail and institutional investors.

MYOB's shares will relist on the ASX on 4 May, where a price somewhere between $3 and $4 per share will be announced on 1 May.

Giving investors a price range rather than an exact dollar figure was a method also used by Medibank Private Ltd (ASX: MPL) late last year, which received criticism due to the uncertainty caused regarding how many shares each investor would actually receive.

Nonetheless, MYOB will boast an enterprise value between $2.34-$2.69 billion while its shares will trade between 20.6 times and 24.9 times pro-forma net profit after tax and amortisation (NPATA). You can read more about the offer by clicking here.

Since lodging its 220-page document however, the group has come under heavy fire from New Zealand-based rival XERO FPO NZ (ASX: XRO), which has insisted that the prospectus does not contain sufficient information relating to its customer numbers.

As highlighted by the Fairfax press, Xero's founder Rod Drury was unhappy that MYOB failed to split up its customer numbers by product, while it also neglected to mention how many cloud-based customers it has in New Zealand. He argues that this does not provide prospective investors with enough information regarding MYOB's actual strength within the market.

In its prospectus, MYOB stated that it had 1.2 million customers for its small business software. Of those, 116,000 are paying users for its cloud-based software while 389,000 are paying desktop users. The remaining 716,000 customers are non-paying users, meaning that they do not pay ongoing maintenance fees.

Of course, it could also be argued that those non-paying users could be turned into paying users in the future which could generate huge amounts of cash for the business. Alternatively, some could argue that some of those customers may not even exist anymore.

Regardless, Drury believes that Xero, which is a pure cloud-accounting software provider, is doing far better in the New Zealand market than MYOB, while it is also quickly gaining traction in Australia. Fairfax quoted Drury as saying: "In NZ it is acknowledged Xero has won. If that is the case, investors will want to know if it is going to happen in Australia too. It is hard to know without breaking out the numbers."

Should you buy MYOB?

MYOB has grown strongly under the control of Bain Capital, which purchased the company in 2011 for $1.2 billion. However, investors need to be sceptical of whether that strong growth can continue long into the future.

As previously mentioned, Xero is also flexing its muscles and certainly looks to have gained the upper hand in many ways. As a perfect example, Motley Fool Pro analyst Matt Joass recently highlighted that Xero's Google search term popularity has surged past MYOB both in Australia/New Zealand, and on a worldwide scale, indicating great things to come for Xero.

Meanwhile, Xero is expanding into the UK and US while MYOB is more focused on the Australasian market.

Of course, investors need to establish for themselves whether an investment in MYOB is right for them and their own personal circumstances. It's also possible that MYOB could initially prove as popular, if not more popular, than Medibank Private when it first listed in November last year, generating investors a nice paper profit early in the keep.

However, there are strong signs that suggest the better investment is already trading on the ASX under the ticker code, "ASX:XRO". I already own shares in Xero and believe they are in a good position to continue delivering sustainable growth in the coming years. As such, it is unlikely that I will be participating in the MYOB IPO in May.

Motley Fool contributor Ryan Newman and the Motley Fool own shares in XERO FPO NZ. The Motley Fool owns shares in XERO. You can follow Ryan on Twitter @ASXvalueinvest We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policyThis article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »